Under Armour Inc. (NYSE: UAA) is scheduled to report earnings results for the third quarter of 2019 on Monday, November 4, before
Under Armour (UAA) earnings preview: What to expect from Q3 results
Categories
Earnings
Seagate (STX) earnings preview: Will focus on big data pay off in Q1?
Seagate Technology (NASDAQ: STX) has been shifting its focus to high-capacity storage systems to ease the pressure on margins due to the
Sanofi (NASDAQ: SNY): Q3 2019 Earnings Snapshot
-- Generic drugmaker Sanofi (NASDAQ: SNY) reported net income of EUR 1.77 billion or EUR 1.49 per share for the third quarter,
Fiat Chrysler to merge with Peugeot; investors ignore lackluster Q3 results
Only a few hours after Fiat Chrysler Automobile (NYSE: FCAU) and French counterpart Peugeot announced a merger, the former reported third-quarter results
SiriusXM (NASDAQ: SIRI): Q3 2019 Earnings Snapshot
-- SiriusXM Holdings Inc. (NASDAQ: SIRI) reported its third-quarter 2019 earnings of $0.05 per share versus $0.06 per share expected. -- Total
World Wrestling Entertainment (WWE): Q3 2019 Earnings Snapshot
-- World Wrestling Entertainment (NYSE: WWE) reported Q3 2019 earnings of $0.06 per share, vs. $0.02 expected. -- Revenues fell 1.1% to
Kraft Heinz (KHC) Q3 2019 Earnings Snapshot
-- Kraft Heinz's (NASDAQ: KHC) third quarter 2019 adjusted EPS decreased 9.2% to $0.69 vs. $0.53 expected. -- Sales declined 4.8% to
International Paper Company (NYSE: IP): Q3 2019 Earnings Snapshot
-- International Paper Company (NYSE: IP) reported adjusted earnings of $1.09 per share for the third quarter of 2019, vs. $0.99 per
Celgene (CELG) Q3 profit jumps 56% beats estimates
Celgene Corporation (NASDAQ: CELG) reported a 56% jump in earnings for the third quarter of 2019 helped by higher revenue as well
Altria Group records $4.5 billion in impairment charges relating to JUUL investment in Q3
Altria Group (NYSE: MO) reported third-quarter net revenues of $6.85 billion, flat year-over-year, primarily driven by higher net revenues in the smokeless
Abiomed’s (ABMD) revenue increases 13% in Q2 on higher usage of Impella; reiterates 2020 outlook
Abiomed (NASDAQ: ABMD) reported a 13% growth in second quarter 2020 revenue, boosted by the increased usage of its Impella heart pumps.
Wayfair (NYSE: W): Q3 2019 Earnings Snapshot
-- Wayfair Inc. (NYSE: W) reported its third-quarter 2019 adjusted loss of $2.23 per share versus $2.10 per share loss expected. --
Bristol-Myers Squibb (BMY) earnings: Q3 results beat amid strong product sales
Driven by the strong sales of leading products, earnings of Bristol-Myers Squibb (NYSE: BMY) increased in the third quarter and exceeded the
Blue Apron’s Q3 results miss expectations
Blue Apron Holdings Inc. (NYSE: APRN) missed revenue and earnings estimates for the third quarter of 2019. The consensus estimate was for
Estée Lauder Q1 profit beats estimates but guides Q2 below consensus
The Estée Lauder Companies Inc. (NYSE: EL) reported a 19% jump in earnings for the first quarter of 2020 due to higher
Marathon Petroleum Corp. (MPC): Q3 2019 Earnings Snapshot
-- Marathon Petroleum Corp. (NYSE: MPC) reported third-quarter 2019 earnings of $1.63 per share, vs. $1.38 per share expected. -- Total revenues
Yeti outperforms in Q3 on strong product offerings; lifts 2019 guidance
Cooler manufacturer Yeti Holdings' (NYSE: YETI) third quarter 2019 earnings results exceeded the market's expectations. The company also lifted its fiscal year
Cigna (NYSE: CI): Q3 2019 Earnings Snapshot
-- Cigna Corporation (NYSE: CI) reported its third-quarter 2019 adjusted operating earnings of $4.54 per share versus $4.36 per share expected. --
Dunkin’ Brands (DNKN): Q3 2019 Earnings Snapshot
-- Dunkin’ Brands Group Inc. (NASDAQ: DNKN) reported Q3 2019 earnings of $0.90 per share, vs. $0.81 expected. -- Revenues grew 1.7%
Western Digital (WDC) Q1 earnings beat; stock falls on weak guidance, CEO exit
After ending the last fiscal year on a dismal note, data storage company Western Digital Corp. (NASDAQ: WDC) reported first-quarter earnings that
ACADIA Pharmaceuticals (ACAD): Q3 2019 Earnings Snapshot
-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) reported Q3 2019 loss of $0.29 per share, vs. $0.40 expected. -- Revenues grew 62% to